Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yichun Wujiashen Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale production of Traditional Chinese Medicine (TCM) products. Based in Yichun, Heilongjiang, the company utilizes the region's abundant natural resources, particularly Acanthopanax senticosus (Siberian Ginseng), to manufacture a variety of therapeutic formulations. Its product portfolio includes injections, capsules, and oral liquids primarily indicated for neurological, cardiovascular, and immunological health. The company operates modern, GMP-certified manufacturing facilities and is recognized as a leading enterprise in the industrialization of Siberian Ginseng extracts in China. Yichun Wujiashen serves a broad domestic market, positioning itself as a key player in the botanical medicine sector of Northeast China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 伊春五加参药业.